
Corteva has delivered a powerful 92.7% total return over the past 5 years, so the key issue now is whether its current US$77.74 share price is adequately supported by the cash flows the business is expected to generate. Recent legal and business developments add fresh context, and raise a clear question for anyone trying to value the stock through its underlying cash generation rather than just its recent share chart.
The stock's next move may depend on whether those cash flows, viewed through a Discounted Cash Flow (DCF) lens, make today's price look well supported or stretched.
For investors weighing whether Corteva's cash flows justify its recent 92.7% 5 year return, a focused screen of other companies can provide useful context, starting with 32 high quality undervalued stocks.
The Discounted Cash Flow (DCF) approach here focuses on the stream of cash Corteva can return to shareholders over time. On the numbers provided, the business has generated trailing twelve month free cash flow of about $615 million in $ terms, with the model assuming that this figure grows from current levels rather than shrinking.
Those projections point to free cash flow rising into the low single digit billions of $ over the next decade, then settling into a more mature growth path, which is typical of a two stage framework. Because the Corteva and Inari settlement transfers intellectual property back to Corteva and clears a legal overhang, that resolution helps explain why a DCF based on these cash flows still places estimated intrinsic value substantially above the current US$77.74 share price. Find out what Corteva could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives pick up where the DCF puzzle for Corteva leaves off. They spell out what would need to happen to growth, margins and earnings for the stock to be worth materially more or less than today’s price on the Community page. Each one ties a specific fair value to a clear storyline about Corteva's possible catalysts and risk factors, so you can track over time which version of events stays closest to reality.
One of the top community narratives on Corteva: 16% undervalued
"The main thing that has to go right is that Corteva delivers on its planned cost savings and productivity programs, including about $500 million of recurring savings in crop protection…"
Discover why this Narrative puts Corteva at 16% undervalued.
Share charts and cash flow models only tell part of the story for Corteva. The internal risk checks have flagged issues that deserve a closer look by anyone considering the stock. Take a closer look at 1 warning sign before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com